* Booth #317 at the Gaylord Palms Resort & Convention Center
* March 14th "Kick-Off Reception" with world-renowned faculty
* Lower Limb product portfolio featured -- both U.S. and Outside
the U.S. products on display
NEW YORK, March 12, 2007 (PRIME NEWSWIRE) -- Small Bone Innovations, Inc. (SBi), a single-source provider of innovation, products, technology and education for the small bone and joint sector of the orthopedic industry, will exhibit at this year's American College of Foot and Ankle Surgeons (ACFAS) 65th Annual Scientific Conference, March 14-18, 2007, at the Gaylord Palms Resort & Convention Center, Orlando, Florida. More than 1,200 surgeons are expected to participate in this year's Conference and over 175 companies will be in attendance.
SBi will open its activities at the 65th Annual Scientific Conference with a Wednesday evening, March 14th "ACFAS Kick-Off Reception" in the Gaylord Palms' Orange Blossom Room. Starting at 5:00pm, guests will be able to interact with SBi's world-renowned lower limb faculty, featuring:
Gary Jolly, DPM, FACFAS
Center for Reconstructive Foot Surgery, Hartford, CT
Guido A. LaPorta, MS, DPM, FACFAS
Regional Foot & Ankle Institute, Scranton, PA
Raymond Smith, DPM, FACFAS
Central Oklahoma Foot and Ankle, Oklahoma City, OK
George Vito, DPM, FACFAS
Foot & Leg Centers of Georgia, Macon, GA
Additionally, Kick-Off Reception guests will be able the meet the SBi Senior Management team, and get a hands on look at SBi's surgeon-innovated, patient-driven, indication-specific lower limb products. Topics to be discussed at this year's reception include: "The Small Bone & Joint Market" and "Circular Fixation Case Studies."
With an extensive and expanding U.S. and Outside the U.S. product portfolio, SBi will have its innovative product and technology systems on full display at Booth #317 inside Orlando's Gaylord Palms Resort & Convention Center, 10:00am to 4:00pm on Thursday, March 15th, 9:30am to 4:00pm on Friday, March 16th, and 9:30am to 2:00pm on Saturday, March 17th.
Commenting on his company's participation at this year's ACFAS Scientific Conference, SBi Founder, Chairman and CEO, Anthony G. Viscogliosi said, "SBi is committed to being the worldwide leader in the design, development, and marketing of arthroplasty, internal and external fixation systems, and tissue repair technology, in the form of implants and related medical technologies. With an anatomical lower limb focus from the toe to below the knee, SBi continues to serve the significant unmet clinical needs of small bone and joint surgeons and their patients. We are proud to participate in this year's Scientific Conference and are excited that 2007 will be the 'Year of the Lower Limb at Small Bone Innovations.'"
About Small Bone Innovations, Inc.
Small Bone Innovations, Inc. (SBi) was founded in 2004 by Viscogliosi Bros., LLC, (VB), the New York-based merchant banking firm that specializes in the musculoskeletal/orthopedic sector. VB created SBi as the first company to focus purely on small bone and joint science. By integrating established companies and professionals in the field, SBi today offers a broad, clinically proven portfolio of innovation, products, technologies and education to treat trauma and disease in small bones and joints.
In establishing SBi, VB acquired several prominent U.S., Canadian and European orthopedic device companies and product technology licenses focused on small bone and joint treatment, including arthroplasty, internal and external fixation, trauma, and tissue technology.
SBi completed a Series B financing, raising a record total of $42.2 million, announced in January, 2006. Based on data provided by Venture Source, this was the largest venture capital investment ever recorded in the field of orthopedic devices.
SBi was a 2006 recipient of Red Herring magazine's annual "Red Herring 100 North America" award, recognized as one of the nation's leading technology companies and the only orthopedic device company selected among an initial entry of more than one thousand firms.
Additionally, SBi's Artelon CMC-I Spacer, developed for patients with thumb base osteoarthritis, was featured on the cover and highlighted within Medical Design Technology magazine's "Year of Innovation" issue as one of the most fascinating technologies influencing the medical device industry.
Medical Device & Diagnostic Industry Magazine named SBi to their list of "50 Companies to Watch" in 2006, noting, "Small Bone Innovations is going against the grain in its determination to become a market leader in the small bone and joint device sector."
For more information on SBi, please visit: www.totalsmallbone.com
The Small Bone Innovations, Inc. logo is available at http://www.primezone.com/newsroom/prs/?pkgid=3091
About Viscogliosi Bros., LLC
Established by Marc R. Viscogliosi, John J. Viscogliosi and Anthony G. Viscogliosi in New York City in 1999, Viscogliosi Bros., LLC (VB) was the first venture capital/private equity and merchant banking firm dedicated to the musculoskeletal/orthopedics sector of the health care industry.
Today, VB is a leading independent firm with a mission to create, build and finance companies founded on innovations developed by surgeons and uniquely focused on "life changing" musculoskeletal/orthopedic technologies. VB has worldwide surgeon, industry and trade relationships and significant financial expertise in the musculoskeletal/orthopedic sector.
As principals of VB, the Viscogliosi brothers have a combined total of more than 40 years' experience analyzing and investing in the musculoskeletal/orthopedics sector, directing literally billions of dollars through the orthopedics industry. They have pioneered innovative financial, strategic and management initiatives for nearly 150 companies in the sector, from start-up, seed and development stage all the way to exit, while helping thousands of people lead better lives through the orthopedic and spinal products marketed and sold by the companies they have assisted in developing and financing.
For more information about VB, please visit: www.vbllc.com
Forward-looking statements
This press release may contain forward-looking statements as defined in the U.S. Private Securities Litigation Reform Act of 1995. Readers are cautioned not to place undue reliance on these forward-looking statements. Actual results may differ materially from those indicated by these forward-looking statements as a result of risks and uncertainties impacting the Company's business including increased competition; the ability of the Company to expand its operations and to attract and retain qualified professionals; technological obsolescence; general economic conditions; and other risks.